Repeated Measurements of Hepatitis B Surface Antigen Identify Carriers of Inactive HBV During Long-term Follow-up

efficacy of hepatitis b vaccine in those who lost hepatitis b surface antigen during follow-up

Hepatitis B Virus Inactive Carriers: Which Follow-up Strategy?

INTRODUCTION The natural history of patients with inactive hepatitis B virus (HBV) is still unclear, persisting doubts about the optimal management of these patients. AIM To evaluate the long-term outcome in a cohort of hepatitis B inactive carriers. METHODS We conducted a retrospective study in a cohort of 100 HBV inactive carriers (categorized after quarterly determinations of serum ALT a...

Long term follow-up and outcome of liver transplantation from hepatitis B surface antigen positive donors

One possibility to increase the organ pool is to use grafts from hepatitis B virus (HBV) surface antigen (HBsAg)-positive donors, but few data are currently available in this setting. Herein, we reviewed the outcome of 92 liver transplantations using allografts from HBsAg-positive donors in the United States (1990-2009). They had experienced HBV-related (n = 68) or HBV-unrelated disease (n = 24...

HBV Treatment in Turkey: The Value of Hepatitis B Surface Antigen Quantification of Chronic Hepatitis B Patients in the Long-term Follow-up—A Single-center Study

Hepatitis B surface antigen (HBsAg) seems to have significant clinical implications to assess the prognosis of chronic hepatitis B (CHB). We assessed HBsAg levels serially in patients with CHB in a single center in Turkey. How to cite this article: Ozkan H. HBV Treatment in Turkey: The Value of Hepatitis B Surface Antigen Quantification of Chronic Hepatitis B Patients in the Long-term Follow-up...

Efficacy of Hepatitis B vaccine in those who lost Hepatitis B surface antigen during follow-up

BACKGROUND The level of HBsAg in some chronic hepatitis B virus (HBV)-infected individuals may decline over time so that it is not detectable in serum. OBJECTIVE To assess the efficacy of HBV vaccine in those who lost their HBsAg without seroconverssion to anti-HBs antibody. PATIENTS AND METHODS From April 1993 to December 2008, of 1603 chronic HBV-infected individuals, 34 (22 men and 12 wo...